Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADRCs for Wrist Osteoarthritis
NCT03503305Active, not recruiting
- Sponsor
- InGeneron
- Start
- Nov 2018
- Primary completion
- Mar 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised, double-blind trial of autologous adipose-derived stem/stromal cells in osteoarthritis (OA) (2 arms), sponsored by InGeneron. Primary endpoint: Incidence of Treatment-Emergent Adverse Events at 12 months. Started Nov 2018; status: active, not recruiting.
02
Drugs
autologous adipose-derived stem/stromal cells
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03503305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03503305.